Back
Astec Industries 10K Form
Sell
32
ASTE
Astec Industries
Last Price:
$33.30
Seasonality Move:
9.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | ASTE/Astec Industries Quarterly |
2024-02-28 | 10K | ASTE/Astec Industries Annual |
2023-11-02 | 10Q | ASTE/Astec Industries Quarterly |
2023-08-03 | 10Q | ASTE/Astec Industries Quarterly |
2023-05-04 | 10Q | ASTE/Astec Industries Quarterly |
2023-03-01 | 10K | ASTE/Astec Industries Annual |
Receive ASTE News And Ratings
See the #1 stock for the next 7 days that we like better than ASTE
ASTE Financial Statistics
Sales & Book Value
Annual Sales: | $1.3B |
---|---|
Cash Flow: | $19.9M |
Price / Cash Flow: | 96.12 |
Annual Sales: | $27.69 |
Price / Book: | 1.2 |
Profitability
EPS (TTM): | -0.08000 |
---|---|
Net Income (TTM): | $-1.9M |
Gross Margin: | $330.8M |
Return on Equity: | -0.3% |
Return on Assets: | -0.18% |
Astec Industries Earnings Forecast
Key Astec Industries Financial Ratios
-
The Gross Profit Margin over the past 39 years for ASTE is 24.72%.
-
The Selling, General & Administrative Expenses for ASTE have been equal to 20.65% of Gross Profit Margin.
-
The Research & Development expenses have been 2.47% of Revenue.
-
The Interest Expense is 26.57% of Operating Income.
-
The Net Earning history of ASTE is 2.50% of Total Revenues.
-
Per Share Earnings over the last 39 years have been positive in 20 years.
Astec Industries Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Machinery |
Sector: | Industrials |
Current Symbol: | ASTE |
CUSIP: | 046224 |
Website: | astecindustries.com |
Debt
Debt-to-Equity Ratio: | 0.18 |
---|---|
Current Ratio: | 2.47 |
Quick Ratio: | 0.83 |
Price-to-Earnings
Trailing P/E Ratio: | 22.65 |
---|---|
Forward P/E Ratio: | 13.11 |
ASTE Technical Analysis vs Fundamental Analysis
Sell
32
Astec Industries (ASTE)
is a Sell
Is Astec Industries a Buy or a Sell?
-
Astec Industries stock is rated a SellThe current Astec Industries [ASTE] share price is $33.29. The Score for ASTE is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.